Methodological Approaches to Validation of Therapeutic Recombinant Proteins Production Based on the Quality by Design Concept
Validation of production processes based on the Quality by Design (QbD) principles calls for thorough scientific understanding of the processes and enhancement of their stability by implementation of new technologies. The aim of the study consisted in substantiating a QbD-based technological approac...
Saved in:
Main Authors: | N. V. Stratonova, A. S. Lisov, A. N. Morozov, D. V. Tyupa, R. A. Khamitov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2018-09-01
|
Series: | Биопрепараты: Профилактика, диагностика, лечение |
Subjects: | |
Online Access: | https://www.biopreparations.ru/jour/article/view/173 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LONG TERM MUCOLYTIC THERAPY WITH DORNASE ALFA AT NOVOSIBIRSK CENTER FOR DIAGNOSTICS, TREATMENT, RHEABILITATION AND ADAPTATION OF CHILDREN WITH CYSTIC FIBROSIS
by: N.I. Romanenko, et al.
Published: (2006-03-01) -
Trends in Life Expectancy of Cystic Fibrosis Patients in Moscow and their Connection with the Treatment Received: Retrospective Analysis for 1993–2013
by: N. Yu. Kashirskaya, et al.
Published: (2015-09-01) -
INFLUENCE OF THE AGE OF THE DIAGNOSIS AND THE BEGINNING OF SPECIFIC THERAPY ON MAIN CLINICAL AND LABORATORY MANIFESTATIONS OF A DISEASE IN PATIENTS WITH CYSTIC FIBROSIS
by: S. A. Krasovskii, et al.
Published: (2014-03-01) -
THE ALGORITHM OF COMPLEX SYNDROME-ORIENTED THERAPY IN CHILDREN WITH CYSTIC FIBROSIS: A MODERN APPROACH
by: Yu. V. Gorinova, et al.
Published: (2013-09-01) -
ROLE OF THE KNOWN MUCOLYTICS IN MUCOVISCIDOSIS THERAPY
by: O. I. Simonova, et al.
Published: (2014-11-01)